Hemocompatibilty

Hemolysis (direct & indirect)Coagulation Platelet Activation Complement Activation Hematology

See more

ISO 10993-1:2025: Enhanced Characterization, Clearer Risk Logic

The 2025 revision keeps biological evaluation firmly inside ISO 14971 risk management and across the full device life cycle. Your…

ISO 10993-1:2025: Risk Management Integration and Exposure Duration

ISO 10993-1:2025 embeds the biological evaluation within ISO 14971’s risk-management framework. The standard explicitly requires identifying biological hazards, estimating their…

Preparing for Biocompatibility Testing: Strategic Considerations for Medical Device Manufacturers

Biocompatibility testing is essential for every medical device, ensuring safety, regulatory approval, and market success. The process, however, can be…

In Vitro & In Vivo: Strategic Insights for Medical Device Leaders

Biocompatibility testing is not just a regulatory requirement—it is a cornerstone of medical device safety, market approval, and long-term trust….

Biocompatibility Requirements for Wearable Medical Devices: Unique Considerations

Wearable medical devices are transforming healthcare with continuous monitoring, real-time diagnostics, and improved patient engagement. However, their design introduces distinct…

Proactive Planning: Combining Biocompatibility with Other Preclinical Testing Needs

Biocompatibility testing is a vital part of preclinical evaluation, but it’s just one piece of the larger puzzle. Manufacturers often…